248 INFLAMMATORY PROFILE IN ICODEXTRIN® selleck screening library TREATED PATIENTS IN AUCKLAND CITY HOSPITAL TY-T SUN1, M YEHIA2 1Middlemore Hospital, Auckland; 2Auckland City Hospital, Auckland, New Zealand Aim: Our aim is to study the inflammatory profile, in a cohort of Auckland City Hospital PD patients who were changed from a glucose-based prescription to Icodextrin®. We also aimed to document important clinical events including hospitalization, peritonitis rate and cardiovascular events. Background: Icodextrin® is a high molecular weight glucose polymer used in peritoneal dialysis (PD) to provide improved ultrafiltration. Emerging studies suggest an enhanced inflammatory state, with

elevated interleukin-6 and C-reactive protein (CRP) with Icodextrin®. Methods: Retrospective find more audit of routinely performed laboratory results and important pre-defined clinical events, for the 12 months period preceding and the 12 months period after the initiation of Icodextrin®, on all Auckland City Hospital PD patients

while in a steady PD state from the 1st of January 2010 to 1st of April 2013. Results: 41 patients were identified who fitted the study inclusion criteria. There was a statistically significant higher serum CRP (10.5 ± 10.6 mg/L vs. 17.3 ± 21.0 mg/L; P = 0.04) and ferritin (477 ± 341 μg/L vs. 652 ± 405 μg/L; P = 0.03) in Icodextrin® treated patients. There was also an increase in hospitalization rates (1.44/person vs. 2.58/person; P = 0.03) and cardiovascular events following start of Icodextrin® (0.17/person vs. 0.48/person; P = 0.03). There was no statistically significant difference in peritonitis episodes (0.34/person vs. 0.67/person; P = 0.11). Conclusions: Our study has demonstrated an elevated inflammatory profile in Icodextrin®-treated population with an increase in hospitalisation and cardiovascular events. However, potential cofounders could not be accounted for, therefore

further study is required to confirm a “pro-inflammatory” state of icodextrin® and its clinical significance. 249 IS THERE A DOWNWARD TREND IN PATIENTS REMAINING ON PERITONEAL DIALYSIS – A SINGLE CENTRE EXPERIENCE STHOKALA, R DWARAKANATHAN Royal Brisbane and Women’s Hospital, Brisbane, Australia Background: There is a misconception Ceramide glucosyltransferase that there is a downward trend in patients opting for peritoneal dialysis. We accessed the data of our peritoneal dialysis patients at our own centre and looked at the trends over the period of six years between 2007 and 2012. Aim: To study the trend in patients remaining on peritoneal dialysis and to identify the reasons if there is a change in the trend. Method: A retrospective analysis of data of all peritoneal dialysis patients registered at our centre during the period 2007–2012 was performed. The prevalent and incident rates of our patients on peritoneal dialysis during the above period were calculated. In addition we also looked at the reasons if there was a downward trend.